Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024

-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion...

Related Keywords

Nick Green ,Globenewswire Inc ,Exchange Commission ,Completion Of Recent Expansion Program ,Nasdaq ,Avid Bioservices Inc ,Third Quarter Revenue ,Net New Business Resulting ,Record High Backlog ,Recent Expansion Program ,Grand Opening ,Gene Therapy Manufacturing Facility ,Convertible Debt Offering Subsequent ,Quarter End ,Extending Debt Maturity ,Quarter Ended ,Convertible Senior Notes ,Exchangeable Senior Notes ,Avid Bioservice Quarterly Report ,Regarding Use ,Avid Bioservices ,Private Securities Litigation Reform Act ,Strategic Partners ,Markets ,